Pablo A Olivera - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Pablo A Olivera

Showing results (11-20 of 32) with videos related to

Pageof 4

Sort By:

Inflammatory Bowel Diseases|September 22, 2023

Endoscopically Active Ulcerative Colitis Is Associated With Asymptomatic Atherosclerotic Vascular Disease: A Case-Control StudyJuan Lasa, Ezequiel Nazario, Gonzalo De Sanctis, et al.

Clinical Epidemiology|January 5, 2026

Validity of the Leading Causes of Death Classification for Premature Mortality in Inflammatory Bowel Disease: A Population-Based Comparison with ICD-10 Coding in Ontario, CanadaGemma Postill, M Ellen Kuenzig, Pablo A Olivera, et al.

The Lancet. Gastroenterology & Hepatology|February 10, 2024

Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin AmericaDomingo Balderramo, Abel Botelho Quaresma, Pablo A Olivera, et al.

Clinical and Experimental Rheumatology|May 4, 2023

Significance of HLA-B[*]51 allele expression in Crohn's disease: a case-control studyAlex Kostianovsky, Pablo E Llanquimán, Pablo A Olivera, et al.

Journal of Crohn'S & Colitis|September 10, 2022

Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPablo A Olivera, Juan S Lasa, Ignacio Zubiaurre, et al.

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 7, 2024

Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensusPablo A Olivera, Axel Dignass, Marla C Dubinsky, et al.

United European Gastroenterology Journal|May 7, 2021

International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseasesFerdinando D'Amico, David T Rubin, Paulo Gustavo Kotze, et al.

World Journal of Hepatology|April 14, 2015

Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3Sebastián Marciano, Silvia M Borzi, Melisa Dirchwolf, et al.

Journal of Clinical Medicine|October 14, 2023

Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi ConsensusFerdinando D'Amico, Virginia Solitano, Fernando Magro, et al.

Autoimmunity Reviews|May 11, 2021

Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensusFerdinando D'Amico, Virginia Solitano, Daniel Aletaha, et al.

Pageof 4

Search research articles

Showing results (11-20 of 32) with videos related to

Sort By:

Pageof 4

Inflammatory Bowel Diseases|September 22, 2023

Endoscopically Active Ulcerative Colitis Is Associated With Asymptomatic Atherosclerotic Vascular Disease: A Case-Control StudyJuan Lasa, Ezequiel Nazario, Gonzalo De Sanctis, et al.

Clinical Epidemiology|January 5, 2026

The Lancet. Gastroenterology & Hepatology|February 10, 2024

Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin AmericaDomingo Balderramo, Abel Botelho Quaresma, Pablo A Olivera, et al.

Clinical and Experimental Rheumatology|May 4, 2023

Significance of HLA-B[*]51 allele expression in Crohn's disease: a case-control studyAlex Kostianovsky, Pablo E Llanquimán, Pablo A Olivera, et al.

Journal of Crohn'S & Colitis|September 10, 2022

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 7, 2024

United European Gastroenterology Journal|May 7, 2021

International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseasesFerdinando D'Amico, David T Rubin, Paulo Gustavo Kotze, et al.

World Journal of Hepatology|April 14, 2015

Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3Sebastián Marciano, Silvia M Borzi, Melisa Dirchwolf, et al.

Journal of Clinical Medicine|October 14, 2023

Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi ConsensusFerdinando D'Amico, Virginia Solitano, Fernando Magro, et al.

Autoimmunity Reviews|May 11, 2021

Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensusFerdinando D'Amico, Virginia Solitano, Daniel Aletaha, et al.

Pageof 4